Leishmaniasis vaccines: past, present and future

Abstract

No vaccine exists against any form of leishmaniasis. Because recovery from infection is usually accompanied by a strong immunity and because it is possible to protect experimental animals against live challenge, hope for the development of a vaccine for humans has been high. However, leishmaniasis is a disease of the poor and the market for a vaccine is very limited. Until a few years ago, with minimal resources, only a pragmatic approach was possible for testing the first-generation vaccines (i.e. killed whole parasites). Recently, funding has become available for developing defined second-generation vaccines, including recombinant proteins and DNA constructs. With new adjuvants also being developed there is new hope, and several new vaccines are in development against leishmaniasis.

Citation

Moddaber, F. Leishmaniasis vaccines: past, present and future. International Journal of Antimicrobial Agents (2010) 36: S58-S61. [DOI: 10.1016/j.ijantimicag.2010.06.024]

Leishmaniasis vaccines: past, present and future

Help us improve GOV.UK

Don’t include personal or financial information like your National Insurance number or credit card details.